STOCK TITAN
  1. Home
  2. Sec-filings
  3. EOLS
  4. [144] Evolus, Inc. SEC Filing

Evolus insider plans sale of 105K common shares

An Evolus, Inc. officer and director filed a Rule 144 notice to potentially sell up to 105,108 common shares valued at about $950,018 as of early September 2026.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Evolus, Inc. (EOLS) insider David Moatazedi filed a notice of proposed sale of company common stock under Rule 144. The filing lists up to 105,108 shares of Evolus common stock to be sold through Morgan Stanley Smith Barney LLC, with an indicated aggregate value of $950,018.66 as of September 2, 2026.

The shares to be sold arise from various equity awards, including performance shares and restricted stock granted on dates in 2025 and 2026. The notice states that the issuer of all these securities is Evolus, Inc., and it is signed by David Moatazedi.

Positive

  • None.

Negative

  • None.
Shares proposed for sale 105,108 shares Common stock covered by the Rule 144 notice through Morgan Stanley Smith Barney LLC
Aggregate market value $950,018.66 Reported value of the 105,108 shares as of September 2, 2026
Trade date reference September 2, 2026 Date associated with the 105,108-share position and value on NASDAQ
Performance shares grant 9,861 shares Common stock performance shares dated December 20, 2025 to be sold
Restricted stock grant 22,415 shares Common stock restricted stock dated January 24, 2026 to be sold
Restricted stock grant 19,860 shares Common stock restricted stock dated January 25, 2026 to be sold
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Performance Shares financial
"Common | 12/20/2025 | Performance Shares | Issuer"
Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.
Restricted Stock financial
"Common | 01/24/2026 | Restricted Stock | Issuer"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Form 144 regulatory
"144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

What does the Form 144 filed for EOLS disclose?
It discloses that insider David Moatazedi has filed a Rule 144 notice for a proposed sale of up to 105,108 shares of Evolus, Inc. common stock through Morgan Stanley Smith Barney LLC, with an indicated value of $950,018.66 as of September 2, 2026.

How many Evolus (EOLS) shares are covered by this Form 144?
The notice covers up to 105,108 shares of Evolus, Inc. common stock, to be sold through Morgan Stanley Smith Barney LLC, as reported in the Rule 144 filing.

What is the reported value of the EOLS shares in the Form 144?
The filing reports an aggregate value of $950,018.66 for the 105,108 Evolus common shares covered by the notice, as of September 2, 2026.

Who is the insider selling Evolus (EOLS) shares under Rule 144?
The insider is David Moatazedi, identified as an officer and director associated with Evolus, Inc., who filed the Rule 144 notice and signed it on September 2, 2026.

What types of Evolus (EOLS) equity awards are being sold?
The securities to be sold include performance shares and restricted stock in Evolus, Inc., granted on several dates in 2025 and 2026, all identified as common stock of the issuer.

On which market are the Evolus (EOLS) shares listed in the Form 144?
The Form 144 identifies the Evolus, Inc. common shares as listed on the NASDAQ market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR